Outcome of FLAG and FLANG Regimens in the Treatment of Acute Leukemias Patients

Outcome of FLAG and FLANG Regimens in the Treatment of Acute Leukemias Patients

Show other versions (1)

Introduction: Despite all improvement in the treatment of acute myeloid leukemia (AML) patients, the management in relapsed or refractory disease is still controversial. The use of multiple chemotherapeutic agents will induce more toxicity and morbidity in patients. Fludarabin- containing therapy (F...

Full description

Bibliographic Details
Main Authors: Kamran Alimoghaddam, Fatemeh Ghaffari, Arash Jalali, Leila Sharifi-Aliabadi, Mohammad Jahani, Eisa Baybordi, Seyyed-Asadollah Mousavi, Masoud Iravani, Babak Bahar, Ardeshir Ghavamzadeh
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2012-09-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
FLAG
FLANG
Acute Leukemias
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/337

Similar Items

Similar Items